Member Info for Traa-dy-Liooar

They had virtually nothing left cash wise in the interims and posted admin costs of £121K. with an overall loss 0f £386k. Rasied 100k mid november so you can make a reasonable estimate. Weshop - market wants to see numbers for users/app etc

Co are just poor with comms. can not see Bond holder being in ny hurry, previous extensions gone to wire. This is going back to.9/.8. we shop is more concerning as it just isnt giving news to the market and will continue its fall. long time to mAy and a another raise will be needed to keep lights on in the intervening period.

Lets hope so because there has been no meaningful news for almost 5 months.

Such a low m/c it could really motor when last of placing is done and news starts arrving.

IMO it is mainly the lack of visibility on the SPAC that is the issue. They gave some deadlines and the suggestion that filings were imminent, but the slippage has been frustrating. They should really let the market know where they are upto. That said if positive news arrives next week we all is forgotten. Having been in MKA for a long time this stance is not unusual from the BoD.

Undoubtedly. but they are getting less and less. Better to get rid of them before news flow.

This quote aged well

"Purchasing a subnet today is like purchasing a building on Fifth Avenue before Manhattan was built up. They are scarce, income-generating assets at the very heart of Bittensor's data economy. Controlling the Tiger Subnet lets us capture protocol fees, earn TAO rewards and steer compute power toward high-value AI services."

Decent day, but the placing overhang has some more to go. Looking forward to news flow

This from 1st Sept. RNS explains the simple and hopefully effective treatment for aglioblastoma cancer that has a terrible prognosis. Hopefully it will prove effective;

ChemoSeed, CRISM's lead product, can be implanted directly into the tumour or the resection margin following the removal of a tumour. This directs that therapeutic concentrations of chemotherapy drugs reach the deep-seated tumour tissue or cover the entire resection margin. In the case of treating glioblastoma, ChemoSeeds can be implanted during surgery thereby bypassing the blood brain barrier, which prevents other treatments from being able to reach the tumour and be effective.

CRISM will initiate its registration-grade Phase 2 clinical trial of irinotecan-ChemoSeed in patients with surgically resectable glioblastoma in Q1 2026.

Don't disagree re the bond and the bond holders stance. They are in a strong position. That is the dilemma the co has.

Https://www.investegate.co.uk/announcement/prn/wecap-plc--wcap/interim-results-to-31-october-2025/9395053

Very lazy cut and paste re the bond. No detail as to where they are up to-very poor from a Bod that should be engaging more with the shareholders. Clearly a raise is needed to keep the lights on. Had virtually no cash at end of period, raised 100k - three months gone so anytime now. I dont see any rush from Bond holder to agree new extention until May.

2 raises in 7 weeks, caught up in the metals boom so make hay etc. reasonable price and warrants at 16p. CEO took a reasonable amount. Early days here so benefit of doubt but would like to see some focusing on timelines for various workstreams.

Bixby has been a complete and utter waste of space.

Interactive investor

The drop over a few days was certainly overdone, and it was entirely due to no real news coming out prior to and as a consequence of the poor webinar. There was an expectation that some updates would be given, maybe new supermarkets on board as previously alluded to by the company. They should be in a position to give an update shortly for the full year. The market is flooded with traders and they have left this last week to chase pastures new, lots of opps with the base metal surges. I took the opp to avergage down and await the next news with interest.

Yes one wouldnt go amiss, particularly when they have alluded to deals being done oin the background inthe podcasts. Time gthey started letting the market know what they have been achieving.

Decent volume today plus 9m.

The pullback will continue as long as weshop keeps dropping a pace- at $57 yesterday - and news awaited on bond. The arbitage is narrowing.

Julian Treger, CoTec CEO commented: "The Expansion Concept Study demonstrates that HyProMag USA's Texas Hub is not a one-off project, but the foundation of a scalable U.S. manufacturing platform. The modular design allows us to replicate capacity efficiently, optimize products for U.S. customers, and accelerate domestic supply chain resilience. With the commissioning of HyProMag plants in the United Kingdom and Germany, along with recent progress on the Texas Hub, materially strengthens HyProMag USA's readiness for the next phase of growth and capital markets engagement."

Germany commissioned?